Analysts Set Expectations for Envoy Medical Q1 Earnings

Envoy Medical, Inc. (NASDAQ:COCH) – Equities researchers at Northland Capmk issued their Q1 2025 earnings per share (EPS) estimates for Envoy Medical in a report issued on Wednesday, April 23rd. Northland Capmk analyst C. Byrnes forecasts that the company will post earnings per share of ($0.35) for the quarter. The consensus estimate for Envoy Medical’s current full-year earnings is ($1.21) per share. Northland Capmk also issued estimates for Envoy Medical’s Q2 2025 earnings at ($0.33) EPS.

Envoy Medical (NASDAQ:COCH) last announced its quarterly earnings results on Friday, March 28th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.12). The firm had revenue of $0.04 million for the quarter, compared to analysts’ expectations of $0.07 million.

Separately, Ascendiant Capital Markets raised their price target on Envoy Medical from $9.00 to $9.25 and gave the stock a “buy” rating in a research note on Monday.

Envoy Medical Stock Up 0.7 %

Shares of Envoy Medical stock opened at $1.46 on Thursday. Envoy Medical has a twelve month low of $1.21 and a twelve month high of $5.42. The company has a market cap of $31.14 million, a price-to-earnings ratio of -1.04 and a beta of 2.35. The company’s 50 day moving average is $1.38 and its 200 day moving average is $1.76.

Hedge Funds Weigh In On Envoy Medical

A number of institutional investors and hedge funds have recently made changes to their positions in COCH. Citadel Advisors LLC bought a new position in Envoy Medical in the fourth quarter worth approximately $42,000. CIBC Private Wealth Group LLC bought a new stake in shares of Envoy Medical during the 4th quarter valued at $65,000. Lake Street Advisors Group LLC purchased a new stake in shares of Envoy Medical in the 4th quarter worth $65,000. Finally, DSG Capital Advisors LLC bought a new position in Envoy Medical in the 4th quarter worth $234,000. Hedge funds and other institutional investors own 8.59% of the company’s stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.